Research here is still evolving, and GLP-1 medications are not FDA-approved treatments for autoimmune disease
3.3 Weight management and body composition optimization: foundational effect for reproductive benefit Across the diverse landscape of evidence involving various comparators and time windows, weight loss and improvements in body composition emerge as the most consistent and clinically interpretable benefit findings of GLP-1RAs in PCOS, particularly within obesity- and IR-dominant phenotypes
First, you can look into formulary exception requests, where your doctor argues that you have a unique medical reason for needing a drug that isn't on the formulary
Curr Diabetes Rep 7:340347
L-CARNITINE IV INFUSION Deficiencies in L-carnitine can lead to tiredness and muscular weaknesses, which may affect the quality and frequency of workouts
Several studies have optimized urea-containing compounds such as SBI-797812 and 1-(2-phenyl-1,3-benzoxazol-6-yl)-3-(pyridin-4-methyl)urea (DS68702229) as potent NAMPT activators, which have been shown to increase NAD + levels in vitro and in vivo, with potential applications in treating metabolic disorders, cardiovascular diseases, and neurodegeneration preclinically 221,222
